SET · BIZ.BK
Business Alignment Public Company Limited
THB 6.00-THB 0.05 (-0.83%)
Business Alignment Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 7.69% below the high.
Loading market information…
SET · BKGI.BK · THB
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:37 AM UTC. Cached market data; not a live quote.
One-year closing-price history · THB. Historical prices are not a forecast.
Bangkok Genomics Innovation Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 9.3% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Bangkok Genomics Innovation Public Company Limited’s forward annual dividend is THB 0.05 per share, paid annual. The forward yield is 2.14% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Bangkok Genomics Innovation Public Company Limited’s next earnings report is currently expected on Nov 11, 2026, with estimated earnings per share of THB 0.02. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Bangkok Genomics Innovation Public Company Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Bangkok Genomics Innovation Public Company Limited, trading as BKGI.BK, is a Thailand-based enterprise delivering a diverse array of clinical and genomic services. Their core genetic offerings include the NIFTY brand for non-invasive prenatal testing, screening for fetal chromosomal abnormalities, and the VISTA brand, which provides genetic disease carrier screening for applications such as pre-embryo implantation, general carrier status, and the detection of gene anomalies linked to thalassemia anemia. Additionally, they offer HPV DNA testing, colon cancer screening under the COLOTECH brand, and personalized genetic analyses through the DNALL brand. Beyond genetic diagnostics, the company provides comprehensive testing for infectious diseases, including real-time PCR, antigen, serology, and neutralizing antibody assays for COVID-19, alongside real-time PCR testing for the monkeypox virus. Their technology solutions segment covers advanced services like DNA and RNA base sequencing, as well as metabolism and protein omics tests. The company also acts as a distributor for essential medical supplies, such as PCR COVID-19 test kits, personal protective equipment (PPE), and vital transport media. BKGI's broader service portfolio encompasses health analytics, medical care, and the development of biotechnology products. They also offer cell advanced therapy medicinal products and provide consulting services for small businesses. Furthermore, the company operates an education center, engages in research activities, and is involved in the retail sale of pharmaceutical products. Remarkably, their operations extend into other sectors, including the provision of heavy machinery such like hydraulic excavators, tractors, wheel-loaded air compressors, and their spare parts, in addition to real estate development. Founded in 2017, Bangkok Genomics Innovation Public Company Limited is headquartered in Bangkok, Thailand.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:34 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 |
|---|
| May 15, 2025 |
| THB 0.01+35.4% vs estimate |
| THB 78.54M-1.83% vs estimate |
| Q4 2024 | Feb 26, 2025 | THB 0.020.0% vs estimate | THB 96.00M+3.23% vs estimate |
|---|
| Q3 2024 | Nov 6, 2024 | THB 0.02+20.0% vs estimate | THB 87.72M-0.32% vs estimate |
|---|
Latest available per-share figures in THB. The payout ratio compares dividends with earnings.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
THB 6.00-THB 0.05 (-0.83%)
Business Alignment Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 7.69% below the high.
THB 12.00THB 0.00 (0.0%)
Aikchol Hospital Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 25.93% below the high.
THB 4.46-THB 0.02 (-0.45%)
Healthlead Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 42.08% below the high.
THB 2.90THB 0.00 (0.0%)
Dental Corporation Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 9.94% below the high.
THB 3.38+THB 0.16 (+4.97%)
Intermedical Care and Lab Hospital Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 21.03% below the high.
THB 1.15+THB 0.01 (+0.88%)
Winnergy Medical Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 23.84% below the high.
THB 0.11+THB 0.01 (+10.0%)
E for L Aim Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 35.29% below the high.
THB 1.29-THB 0.01 (-0.77%)
Kt Medical Service Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 39.72% below the high.